Announced Wed, 24 Jun · 11:36 IST
Trading window closure ahead of Q1 FY26 results
Compliance View source PDF
BALPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.2%1-day move
₹85.40
prior close
₹84.30
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.3+0.3+0.2+0.3-3.2-7.3-8.4-6.2-7.4-10.8+1.9+2.3——
Up moveDown movePending
AI summary
Bal Pharma has informed the exchanges that the trading window for designated persons and their immediate relatives will be closed from July 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter ended June 30, 2026. The board meeting date for results will be announced later. This is a routine insider trading compliance measure under SEBI rules.
Likely market impact
No direct impact on shareholders. Insiders barred from trading until results are declared. Signals upcoming Q1 results announcement.